Neoadjuvant carboplatin in triple-negative breast cancer: results from NACATRINE, a randomized phase II clinical trial.

Autor: de Pádua Souza C; Barretos Cancer Hospital, Barretos, SP, Brazil. crispadua10@gmail.com., Carneiro ASB; Barretos Cancer Hospital, Barretos, SP, Brazil., de Oliveira Lessa AC; Barretos Cancer Hospital, Barretos, SP, Brazil., Lacerda DC; Barretos Cancer Hospital, Barretos, SP, Brazil., Paiva CE; Barretos Cancer Hospital, Barretos, SP, Brazil., Zorzetto MMC; Barretos Cancer Hospital, Barretos, SP, Brazil., de Freitas AJA; Molecular Oncology Research Center, Barretos Cancer Hospital, Teaching and Research Institute, Barretos, SP, Brazil., Santana IVV; Pathology Department, Barretos Cancer Hospital, Barretos, SP, Brazil., de Oliveira MA; Nucleus of Epidemiology and Biostatistics, Barretos Cancer Hospital, Barretos, SP, Brazil., Palmero EI; Molecular Oncology Research Center, Barretos Cancer Hospital, Teaching and Research Institute, Barretos, SP, Brazil.; Department of Genetics, Brazilian National Cancer Institute, Rio de Janeiro, Brazil., Marques MMC; Molecular Oncology Research Center, Barretos Cancer Hospital, Teaching and Research Institute, Barretos, SP, Brazil., Reinert T; Oncoclinicas, Porto Alegre, Brazil.; Grupo Brasileiro de Estudos em Câncer de Mama (GBECAM), Porto Alegre, Brazil.

Publikováno v: Breast cancer research and treatment [Breast Cancer Res Treat] 2023 Nov; Vol. 202 (1), pp. 57-65. Date of Electronic Publication: 2023 Aug 14.